Management of BIRADS 4C Breast Lesions

Diagnosis and Initial Management

For a patient with a BIRADS 4C breast lesion, core needle biopsy is necessary for tissue diagnosis before proceeding with definitive management, as recommended by the National Comprehensive Cancer Network 1, 2
BIRADS 4C indicates a high suspicion for malignancy with a risk of malignancy between 50-95%, according to the American College of Radiology 3
Confirm that the core needle biopsy has been performed as indicated in the report, ensuring timely diagnosis and treatment, as per the National Comprehensive Cancer Network guidelines 1, 4

If biopsy results are malignant, refer to breast cancer treatment guidelines for comprehensive management, including additional imaging for staging and multidisciplinary discussion with surgical oncology, medical oncology, and radiation oncology, as recommended by the National Comprehensive Cancer Network 1, 4
If biopsy results are benign but discordant with imaging findings, surgical excision is recommended due to the high suspicion features on imaging, as per the National Comprehensive Cancer Network guidelines 5, 6
For benign lesions concordant with imaging, physical examination with or without ultrasound or mammogram every 6-12 months for 1-2 years to assess stability, as recommended by the National Comprehensive Cancer Network 6, 7

Avoid delaying definitive diagnosis as this could result in delayed treatment of potential malignancy, emphasizing the importance of thorough diagnostic evaluation, as noted by the American College of Radiology 2
For patients with BIRADS 4C lesions, the absence of suspicious axillary lymph nodes is a favorable finding but does not reduce the need for complete diagnostic workup, as per the National Comprehensive Cancer Network guidelines 4